We productively manage relationships with our investors, shareholders and analysts, and promote the attractiveness of our stock through range of activities.
- Total business volume grew organically by 9% YoY to EUR 1,868.3 million. Including the new business from the Italian market, the total business volume amounted to EUR 2,561.2 million (49% growth). Organic growth was achieved across all business segments.
- Earnings before tax rose by 9% to EUR 174.1 million, while net earnings increased by 4% to EUR 136.7 million.
- Combined ratio Non-Life and Health stood at a favourable 93.2% (2024: 93.6%), while the new business margin Life stood at 13.3% (2024: 13.4%). The return on equity was 13.2% (2024: 14.0%).
- Capital adequacy at year-end remained within the target range of 200–250%. As at 31 December 2025, Triglav's market capitalisation reached EUR 1.3 billion, the dividend yield was 4.7% and total share return stood at 50.9%.
- 2026 Plan: The Group plans earnings before tax of EUR 170–190 million, with a total business volume exceeding EUR 2.4 billion, and the combined ratio Non-Life and Health of around 95%.
More in the press release.